IBA, Framatome Form Joint Venture to Produce Astatine — 211 for Cancer Therapies
IBA and Framatome formed Ekalia, a jointly owned venture to industrialize astatine-211 production for targeted cancer therapies. The venture plans a production network across Europe and North America, combining cyclotron technology with nuclear industrial expertise. Its first site in Nantes, France, is expected to beco